Literature DB >> 24049149

Nitro-oleic acid is a novel anti-oxidative therapy for diabetic kidney disease.

Madhav C Menon1, Peter Y Chuang, John C He.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24049149      PMCID： PMC3882365          DOI： 10.1152/ajprenal.00489.2013

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN： 1522-1466


× No keyword cloud information.
  28 in total

1.  Diabetic nephropathy: Could problems with bardoxolone methyl have been predicted?

Authors:  Peter Rossing
Journal:  Nat Rev Nephrol       Date:  2013-02-05       Impact factor: 28.314

2.  Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.

Authors:  D Koya; M Haneda; H Nakagawa; K Isshiki; H Sato; S Maeda; T Sugimoto; H Yasuda; A Kashiwagi; D K Ways; G L King; R Kikkawa
Journal:  FASEB J       Date:  2000-03       Impact factor: 5.191

3.  Effects of Endogenous PPAR Agonist Nitro-Oleic Acid on Metabolic Syndrome in Obese Zucker Rats.

Authors:  Haiping Wang; Haiying Liu; Zhanjun Jia; Guangju Guan; Tianxin Yang
Journal:  PPAR Res       Date:  2010-07-05       Impact factor: 4.964

4.  Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions.

Authors:  Francisco J Schopfer; Marsha P Cole; Alison L Groeger; Chen-Shan Chen; Nicholas K H Khoo; Steven R Woodcock; Franca Golin-Bisello; U Nkiru Motanya; Yong Li; Jifeng Zhang; Minerva T Garcia-Barrio; Tanja K Rudolph; Volker Rudolph; Gustavo Bonacci; Paul R S Baker; H Eric Xu; Carlos I Batthyany; Y Eugene Chen; Tina M Hallis; Bruce A Freeman
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

5.  Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.

Authors:  Shuei-Liong Lin; Yung-Ming Chen; Wen-Chih Chiang; Kwan-Dun Wu; Tun-Jun Tsai
Journal:  Am J Kidney Dis       Date:  2008-07-09       Impact factor: 8.860

6.  Nrf2-dependent and -independent responses to nitro-fatty acids in human endothelial cells: identification of heat shock response as the major pathway activated by nitro-oleic acid.

Authors:  Emilia Kansanen; Henna-Kaisa Jyrkkänen; Oscar L Volger; Hanna Leinonen; Annukka M Kivelä; Sanna-Kaisa Häkkinen; Steven R Woodcock; Francisco J Schopfer; Anton J Horrevoets; Seppo Ylä-Herttuala; Bruce A Freeman; Anna-Liisa Levonen
Journal:  J Biol Chem       Date:  2009-10-05       Impact factor: 5.157

Review 7.  AGE, RAGE, and ROS in diabetic nephropathy.

Authors:  Adeline L Y Tan; Josephine M Forbes; Mark E Cooper
Journal:  Semin Nephrol       Date:  2007-03       Impact factor: 5.299

8.  Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice.

Authors:  Ying Liu; Zhanjun Jia; Shanshan Liu; Maicy Downton; Gang Liu; Yaomin Du; Tianxin Yang
Journal:  Am J Physiol Renal Physiol       Date:  2013-08-14

9.  Nitro-oleic acid protects against endotoxin-induced endotoxemia and multiorgan injury in mice.

Authors:  Haiping Wang; Haiying Liu; Zhanjun Jia; Zhunjun Jia; Curtis Olsen; Sheldon Litwin; Guangju Guan; Tianxin Yang
Journal:  Am J Physiol Renal Physiol       Date:  2009-12-23

10.  Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline.

Authors:  Nilka Ríos Burrows; Yanfeng Li; Linda S Geiss
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112
View more
  2 in total

Review 1.  Nitro-fatty acids in cardiovascular regulation and diseases: characteristics and molecular mechanisms.

Authors:  Luis Villacorta; Zhen Gao; Francisco J Schopfer; Bruce A Freeman; Y Eugene Chen
Journal:  Front Biosci (Landmark Ed)       Date:  2016-01-01

Review 2.  New Insights into the PPAR γ Agonists for the Treatment of Diabetic Nephropathy.

Authors:  Zhanjun Jia; Ying Sun; Guangrui Yang; Aihua Zhang; Songming Huang; Kristina Marie Heiney; Yue Zhang
Journal:  PPAR Res       Date:  2014-01-29       Impact factor: 4.964
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.